SCHEMBL31031214

SCHEMBL31031214

C=C(F)c1ccc2c(c1)nc1cc(N3CC(O)C3)ccn12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31031218 0.81 SUV39H2 (0.34)
SCHEMBL31031233 0.80
SCHEMBL31031212 0.79 ALDH1A1 (0.39) MAPK8
SCHEMBL31031230 0.78 CYP2D6 (0.35)
SCHEMBL31031232 0.78 KCNH2 (0.34)
SCHEMBL31031245 0.76 KDM4E (0.38)
SCHEMBL31031251 0.75 SUV39H2 (0.35)
SCHEMBL31031240 0.75
SCHEMBL31031241 0.74 KDM4E (0.37)
SCHEMBL18838775 0.73 IKBKB (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658651-A1 NOVEL COMPOUNDS FOR TAU IMAGING Eli Lilly and Company (US) 2025-12-10 EP disclosed
WO-2024163546-A1 NOVEL COMPOUNDS FOR TAU IMAGING ELI LILLY AND COMPANY (US) 2024-08-08 WO disclosed